Response to 'Lapses at the NEJM'.
Drazen
Jeffrey M
JM
D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D032984:Ethics, Research; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D010506:Periodicals as Topic / Q000941:ethics*; D016032:Randomized Controlled Trials as Topic; D013450:Sulfones / Q000009:adverse effects*; D014481:United States
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib